Felistas Mbewe

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

Moses Sinkala, Felistas Mbewe, Ronald A. Cantrell et al. · The Lancet · 2007 · 106 citations

Pharmacy, Maternal Health, Pharmacotherapy +17

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial

Joan T. Price, Bellington Vwalika, Bethany L. Freeman et al. · The Lancet HIV · 2021 · 28 citations · Full text

Medicine, Maternal Health, Obstetrics +16

Single-Dose Tenofovir and Emtricitabine for Reduction of Viral Resistance to Non-nucleoside Reverse Transcriptase Inhibitory Drugs in Women Given Intrapartum Nevirapine for Perinatal HIV Prevention: An Open-Label Randomized Trial

Moses Sinkala, Felistas Mbewe, Ronald A. Cantrell et al. · Obstetrical & Gynecological Survey · 2008 · 24 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Addition of Single-Dose Tenofovir and Emtricitabine to Intrapartum Nevirapine to Reduce Perinatal HIV Transmission

Namwinga Chintu, Ronald A. Cantrell, Chipepo Kankasa et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 22 citations

Public Health, Maternal Health, Pharmacotherapy +17

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

Joan T. Price, Bellington Vwalika, Bethany L. Freeman et al. · BMC Pregnancy and Childbirth · 2019 · 19 citations · Full text

Medicine, Maternal Health, Obstetrics +15